We are live on ! Find out more
PHS

Pekin Hardy Strauss Portfolio holdings

AUM $1.14B
1-Year Est. Return 37.36%
This Fund
S&P 500
This Quarter Est. Return
-4.08%
1 Year Est. Return
+37.36%
3 Year Est. Return
+102.22%
5 Year Est. Return
+128.49%
10 Year Est. Return
+317.35%
AUM
$589M
AUM Growth
-$47.6M
Cap. Flow
-$13M
Cap. Flow %
-2.2%
Top 10 Hldgs %
49.28%
Holding
147
New
6
Increased
45
Reduced
57
Closed
6

Top Buys

Rank Stock Value
1
DF
Dean Foods Company
DF
+$8.15M
2
TWI icon
Titan International
TWI
+$4.85M
3
PHYS icon
Sprott Physical Gold
PHYS
+$2.74M
4
TDC icon
Teradata
TDC
+$1.38M
5
RTK
Rentech, Inc.
RTK
+$1.35M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.15M
2
JBSS icon
John B. Sanfilippo & Son
JBSS
+$5.67M
3
SPLS
Staples Inc
SPLS
+$5.3M
4
NBR icon
Nabors Industries
NBR
+$3.72M
5
SKM icon
SK Telecom
SKM
+$3.52M

Sector Composition

Rank Sector Weight
1 Financials 21.83%
2 Healthcare 13.11%
3 Industrials 10.77%
4 Consumer Staples 9.83%
5 Materials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
126
Walt Disney
DIS
$167B
$227K 0.04%
2,546
+133
+6% +$11.7K
ADM icon
127
Archer Daniels Midland
ADM
$38.9B
$208K 0.04%
+4,078
New +$200K
SE
128
DELISTED
Spectra Energy Corp Wi
SE
$208K 0.04%
5,306
-500
-9% -$20.6K
ORCL icon
129
Oracle
ORCL
$367B
$204K 0.03%
5,342
+300
+6% +$12.1K
LUMO
130
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$203K 0.03%
1,056
– –
JFR icon
131
Nuveen Floating Rate Income Fund
JFR
$1.23B
$186K 0.03%
16,450
– –
ABEV icon
132
Ambev
ABEV
$48.2B
$183K 0.03%
28,000
– –
HIX
133
Western Asset High Income Fund II
HIX
$350M
$166K 0.03%
18,500
– –
SVU
134
DELISTED
SUPERVALU Inc.
SVU
$149K 0.03%
2,375
– –
VERU icon
135
Veru
VERU
$35.6M
$135K 0.02%
3,860
– –
ACHN
136
DELISTED
Achillion Pharmaceuticals
ACHN
$110K 0.02%
11,000
+500
+5% +$4.64K
GAB icon
137
Gabelli Equity Trust
GAB
$1.76B
$100K 0.02%
16,169
-372
-2% -$2.58K
PIM
138
Franklin Master Intermediate Income Trust
PIM
$149M
$65K 0.01%
12,950
– –
OPHC icon
139
OptimumBank Holdings
OPHC
$86.5M
$21K ﹤0.01%
1,617
+121
+8% +$1.61K
APP
140
DELISTED
AMERICAN APPAREL INC COM
APP
$8K ﹤0.01%
10,000
– –
GAB.RT
141
DELISTED
GABELLI EQUITY TR INC RTS EXP 10/20/14 (MD)
GAB.RT
$1K ﹤0.01%
+15,701
New +$1.2K
BLK icon
142
Blackrock
BLK
$170B
– –
-849
Closed -$271K
CSX icon
143
CSX Corp
CSX
$93B
– –
-25,500
Closed -$262K
INTC icon
144
Intel
INTC
$460B
– –
-15,639
Closed -$483K
KMI icon
145
Kinder Morgan
KMI
$70.5B
– –
-6,000
Closed -$218K
MGA icon
146
Magna International
MGA
$19B
– –
-4,000
Closed -$215K
APC
147
DELISTED
Anadarko Petroleum
APC
– –
-2,000
Closed -$219K
2 3 4 5
6

Similar funds

ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
SAM
SP Asset Management Cupertino, California $1.13B AUM 12.57% 1-Year Est. Return
HMCP
Hook Mill Capital Partners New York $1.13B AUM 31.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.13B AUM 70.63% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
AT
American Trust Lexington, Kentucky $1.13B AUM 17.56% 1-Year Est. Return
RPC
Rossmore Private Capital Glastonbury, Connecticut $1.14B AUM 23.53% 1-Year Est. Return

Pekin Hardy Strauss's Q3 2014 Portfolio in Review

As of Q3 2014, Pekin Hardy Strauss held 147 positions worth $589M, down 7.5% from $637M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Pekin Hardy Strauss's Q3 2014 filing shows 6 new, 45 increased, 57 reduced and 6 closed positions. Its largest new stake was Dean Foods Company: 512,907 shares worth $6.8M. The largest sale was Teva Pharmaceuticals, an estimated $7.15M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Pekin Hardy Strauss's largest Q3 2014 buy was Dean Foods Company: 512,907 shares worth $6.8M.
  • Pekin Hardy Strauss added most to Titan International in Q3 2014, an estimated $4.85M increase.
  • Pekin Hardy Strauss's biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $7.15M.
  • Pekin Hardy Strauss fully exited Intel in Q3 2014, selling an estimated $483K.
  • Pekin Hardy Strauss's ten largest holdings make up 49% of its $589M portfolio in Q3 2014.
  • Pekin Hardy Strauss opened 6 new positions and closed 6 in Q3 2014.
  • Pekin Hardy Strauss's portfolio value fell 7.5% quarter-over-quarter to $589M.

Based on Pekin Hardy Strauss's 13F filing for Q3 2014, filed 14 Nov 2014.